These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2777203)

  • 21. A controlled trial of D-penicillamine therapy in primary biliary cirrhosis.
    Jain S; Scheuer PJ; Samourian S; McGee JO
    Lancet; 1977 Apr; 1(8016):831-4. PubMed ID: 67338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
    Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined ursodeoxycholic acid plus colchicine--treatment of primary biliary cirrhosis: results of a placebo-controlled double-blind study].
    Raedsch R; Stiehl A; Walker S; Scherrmann JM; Kommerell B
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():55-7. PubMed ID: 1449019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study.
    Goffin E; Devogelaer JP; Depresseux G; Squifflet JP; Pirson Y; van Yperselede de Strihou C
    Clin Nephrol; 2003 Mar; 59(3):190-5. PubMed ID: 12653262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver.
    Parés A; Caballería L; Rodés J; Bruguera M; Rodrigo L; García-Plaza A; Berenguer J; Rodríguez-Martínez D; Mercader J; Velicia R
    J Hepatol; 2000 Apr; 32(4):561-6. PubMed ID: 10782903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymptomatic primary biliary cirrhosis. Presentation, histology, and results with D-penicillamine.
    Fleming CR; Ludwig J; Dickson ER
    Mayo Clin Proc; 1978 Sep; 53(9):587-93. PubMed ID: 355732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low bone turnover state in primary biliary cirrhosis.
    Stellon AJ; Webb A; Compston J; Williams R
    Hepatology; 1987; 7(1):137-42. PubMed ID: 3804193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy.
    Zifroni A; Schaffner F
    Hepatology; 1991 Dec; 14(6):990-3. PubMed ID: 1959887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis.
    Wiesner RH; Ludwig J; Lindor KD; Jorgensen RA; Baldus WP; Homburger HA; Dickson ER
    N Engl J Med; 1990 May; 322(20):1419-24. PubMed ID: 2184355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective trial of D-penicillamine in primary biliary cirrhosis.
    Matloff DS; Alpert E; Resnick RH; Kaplan MM
    N Engl J Med; 1982 Feb; 306(6):319-26. PubMed ID: 7033789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of primary biliary cirrhosis with low-dose weekly methotrexate.
    Kaplan MM; Knox TA
    Gastroenterology; 1991 Nov; 101(5):1332-8. PubMed ID: 1936805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis.
    Bergasa NV; Jones A; Kleiner DE; Rabin L; Park Y; Wells MC; Hoofnagle JH
    Am J Gastroenterol; 1996 Feb; 91(2):295-9. PubMed ID: 8607496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis.
    Neuberger J; Christensen E; Portmann B; Caballeria J; Rodes J; Ranek L; Tygstrup N; Williams R
    Gut; 1985 Feb; 26(2):114-9. PubMed ID: 3881323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized trial of chlorambucil for primary biliary cirrhosis.
    Hoofnagle JH; Davis GL; Schafer DF; Peters M; Avigan MI; Pappas SC; Hanson RG; Minuk GY; Dusheiko GM; Campbell G
    Gastroenterology; 1986 Dec; 91(6):1327-34. PubMed ID: 3533699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group.
    Poupon R; Chazouillères O; Balkau B; Poupon RE
    J Hepatol; 1999 Mar; 30(3):408-12. PubMed ID: 10190722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis.
    Batts KP; Jorgensen RA; Dickson ER; Lindor KD
    Am J Gastroenterol; 1996 Nov; 91(11):2314-7. PubMed ID: 8931409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis.
    Kaplan MM; Schmid C; Provenzale D; Sharma A; Dickstein G; McKusick A
    Gastroenterology; 1999 Nov; 117(5):1173-80. PubMed ID: 10535881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Methotrexate in the therapy of primary biliary cirrhosis].
    Weber P; Scheurlen M; Wiedmann KH
    Dtsch Med Wochenschr; 1991 Sep; 116(36):1347-52. PubMed ID: 1884674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The results of a randomized double blind controlled trial evaluating malotilate in primary biliary cirrhosis. A European multicentre study group.
    J Hepatol; 1993 Feb; 17(2):227-35. PubMed ID: 8445237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.